Tectonic Therapeutic, Inc.
TECX
$21.89
-$0.55-2.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.83% | -9.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.78% | -28.75% | |||
| Operating Income | -30.78% | 28.75% | |||
| Income Before Tax | -28.55% | 30.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -28.55% | 30.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.55% | 30.16% | |||
| EBIT | -30.78% | 28.75% | |||
| EBITDA | -33.04% | 29.82% | |||
| EPS Basic | -10.83% | 30.47% | |||
| Normalized Basic EPS | -10.83% | 30.46% | |||
| EPS Diluted | -10.83% | 30.47% | |||
| Normalized Diluted EPS | -10.83% | 30.46% | |||
| Average Basic Shares Outstanding | 15.99% | 0.43% | |||
| Average Diluted Shares Outstanding | 15.99% | 0.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||